Antisoma is engaged in pharmaceutical research and development. Co. specializes in the development of anti cancer drugs. Through its subsidiaries, Co. is engaged in the development and commercialization of potential therapeutic products for the treatment of cancer.
Quote | Sarossa PLC (OTCMKTS:AIOAF)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $15.00 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 02/12/2020 04:20:14 pm |
News | Sarossa PLC (OTCMKTS:AIOAF)
Message Board Posts | Sarossa PLC (OTCMKTS:AIOAF)
Subject | By | Source | When |
---|---|---|---|
AIOAF FINRA deleted symbol: | Renee | investorshub | 08/05/2020 10:43:49 PM |
AIOAF .0007/interesting volume lately | ToyotaMR2s | investorshub | 07/06/2017 1:38:45 PM |
Stock_Tracker: Latest Antisoma Plc (AIOAF) Headlines Inflammatory Bowel Disease - Pipeline Review, H | Stock_Tracker | investorshangout | 03/08/2014 11:03:15 PM |
chartguy89: AIOAF 0.02 Stock Charts $AIOAF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 1:19:14 AM |
Stock_Tracker: AIOAF Recent News Inflammatory Bowel Disease - Pipeline Review, H2 2012 Out Now M2 - | Stock_Tracker | investorshangout | 03/02/2014 3:58:53 PM |